查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2044771

自體免疫疾病治療市場報告：趨勢、預測和競爭分析（至2035年）

Autoimmune Treatment Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球自體免疫疾病治療市場前景廣闊，風濕性疾病、第一型糖尿病、多發性硬化症和發炎性腸道疾病等領域預計將出現成長機會。預計2026年至2035年，全球自體免疫疾病治療市場將以5.2%的年複合成長率成長，到2035年市場規模預計將達到3,190億美元。推動該市場成長的關鍵因素包括：對標靶治療方案的需求不斷成長、醫療保健支出增加以支持治療的普及，以及先進生物製藥研究的進展。

  • 根據 Lucintel 的預測，在預測期內，藥物類別的成長率預計將高於疾病類型的成長率。
  • 就適應症而言，預計多發性硬化症的成長率最高。
  • 按地區分類，預計亞太地區在預測期內將呈現最高的成長率。

自體免疫疾病治療市場的新趨勢

自體免疫療法市場正受到醫學研究進展和對有效治療方法日益成長的需求的影響。藥物研發和個人化醫療的創新正在改變治療方法。這些趨勢反映出自體免疫疾病的治療正朝著更具針對性、更有效率、以患者為中心的解決方案轉變。

  • 標靶生物製藥療法的進展：針對特定免疫路徑開發的生物製藥正在改善治療效果。這些治療方法能夠實現更精準的疾病管理。
  • 個人化醫療方法的拓展：基於基因和臨床數據的個人化治療方案越來越受到關注，這有助於提高治療效果，並改善患者的治療結果。
  • 生物相似藥的廣泛應用：生物相似藥的廣泛應用提高了治療的可及性和可負擔性。這些藥物正在幫助更多患者獲得治療。
  • 先進診斷技術的整合：診斷工具的改進能夠實現疾病的早期發現和更有效的疾病管理。這些技巧有助於制定精準的治療方案。
  • 口服和注射治療方法的創新：新型給藥方式的開發提高了患者的用藥便利性和依從性，從而改善了治療體驗。

這些新趨勢正在透過提高治療的精準性、可近性和改善患者療效，重塑自體免疫疾病治療市場。持續創新正在推動針對不斷變化的醫療保健需求而開發的先進治療方法的研發。

自體免疫療法市場的最新趨勢

在科學研究和醫療創新推動下，自體免疫疾病治療市場正穩步發展。發展重點在於提高治療效果、拓展治療選擇、改善各類自體免疫疾病患者照護。

  • 新一代生物製藥的研發：先進生物製藥的研發正在改善疾病管理和治療效果。這些治療方法針對特定的免疫反應。
  • 與先進診斷系統整合的進展：治療方法正與診斷工具相圖，以提高準確性和有效性。這種整合正在提升病患照護品質。
  • 生物相似藥供應範圍擴大：生物相似藥供應範圍的擴大正在改善患者獲得治療的機會。這些藥物有助於實現更具成本效益的醫療保健解決方案。
  • 藥物輸送系統創新：改良的輸送方法提高了患者的用藥便利性和依從性，從而有助於有效治療。
  • 重視聯合治療：合併使用不同的治療方法可以改善治療效果。這些方法能夠解決複雜的疾病機制。

這些進展正在增強自體免疫。持續的創新正在提高療效、可近性和患者照護，從而更好地管理自體免疫疾病。

目錄

第1章：執行摘要

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球自體免疫疾病治療市場：按類型分類

  • 吸引力分析：按類型
  • 藥物類別
  • 外科手術

第5章：全球自體免疫疾病治療市場：依適應症分類

  • 吸引力分析：按指標
  • 風濕病
  • 1型糖尿病
  • 多發性硬化症
  • 發炎性腸道疾病
  • 其他

第6章 區域分析

第7章：北美自體免疫疾病治療市場

  • 北美自體免疫疾病治療市場：按類型分類
  • 北美自體免疫疾病治療市場：依適應症分類
  • 美國自體免疫疾病治療市場
  • 加拿大自體免疫疾病治療市場
  • 墨西哥自體免疫疾病治療市場

第8章：歐洲自體免疫疾病治療市場

  • 歐洲自體免疫疾病治療市場：按類型分類
  • 歐洲自體免疫疾病治療市場：依適應症分類
  • 德國自體免疫疾病治療市場
  • 法國自體免疫疾病治療市場
  • 義大利自體免疫疾病治療市場
  • 西班牙自體免疫疾病治療市場
  • 英國自體免疫疾病治療市場

第9章：亞太地區自體免疫疾病治療市場

  • 亞太地區自體免疫疾病治療市場：按類型分類
  • 亞太地區自體免疫疾病治療市場：依適應症分類
  • 中國自體免疫疾病治療市場
  • 印度自體免疫疾病治療市場
  • 日本自體免疫疾病治療市場
  • 韓國自體免疫疾病治療市場
  • 印尼自體免疫疾病治療市場

第10章：世界其他地區自體免疫疾病療法市場

  • 其他地區的自體免疫疾病治療市場：按類型分類
  • 其他地區的自體免疫疾病治療市場：依適應症分類
  • 中東自體免疫疾病治療市場
  • 南非自體免疫疾病治療市場
  • 非洲自體免疫疾病治療市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球自體免疫疾病治療市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • 競爭分析概述
  • AbbVie Inc
  • Amgen Inc
  • Johnson & Johnson
  • Eli Lilly & Co.
  • Pfizer Inc
  • F. Hoffmann-La Roche
  • AstraZeneca plc
  • Bristol-Myers Squibb
  • Lupin Ltd
  • GSK plc

第14章附錄

The future of the global autoimmune treatment market looks promising with opportunities in the rheumatic disease, type 1 diabetes, multiple sclerosis, and inflammatory bowel disease markets. The global autoimmune treatment market is expected to reach an estimated $319 billion by 2035 with a CAGR of 5.2% from 2026 to 2035. The major drivers for this market are the increasing demand for targeted therapy solutions, the rising healthcare expenditure supporting treatment access, and the growing research in advanced biologic drugs.

  • Lucintel forecasts that, within the type category, drug class is expected to witness higher growth over the forecast period.
  • Within the indication category, multiple sclerosis is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Autoimmune Treatment Market

The autoimmune treatment market is being shaped by advancements in medical research and increasing demand for effective therapies. Innovations in drug development and personalized medicine are transforming treatment approaches. These trends reflect a shift toward more targeted, efficient, and patient-centric solutions for managing autoimmune diseases.

  • Targeted Biologic Therapy Advancement: Development of biologics targeting specific immune pathways is improving treatment outcomes. These therapies provide more precise disease management.
  • Personalized Medicine Approach Growth: Increasing focus on personalized treatment plans based on genetic and clinical data is enhancing effectiveness. These approaches improve patient outcomes.
  • Biosimilar Drug Adoption Expansion: Growing use of biosimilars is improving accessibility and affordability of treatments. These drugs support broader patient access.
  • Advanced Diagnostic Technology Integration: Improved diagnostic tools are enabling early detection and better disease management. These technologies support accurate treatment planning.
  • Oral And Injectable Therapy Innovation: Development of new delivery methods is improving patient convenience and adherence. These innovations enhance treatment experience.

These emerging trends are reshaping the autoimmune treatment market by enhancing precision, accessibility, and patient outcomes. Continuous innovation is supporting the development of advanced therapies aligned with evolving healthcare needs.

Recent Developments in the Autoimmune Treatment Market

The autoimmune treatment market is experiencing steady advancements driven by scientific research and healthcare innovation. Developments focus on improving treatment effectiveness, expanding therapeutic options, and enhancing patient care across various autoimmune conditions.

  • Next Generation Biologic Drug Development: Development of advanced biologics is improving disease management and treatment outcomes. These therapies target specific immune responses.
  • Integration With Advanced Diagnostic Systems Growth: Treatments are being aligned with diagnostic tools to improve accuracy and effectiveness. This integration supports better patient management.
  • Expansion Of Biosimilar Drug Availability: Increased availability of biosimilars is improving access to treatment. These drugs support cost-effective healthcare solutions.
  • Innovations In Drug Delivery Systems: Development of improved delivery methods is enhancing patient convenience and adherence. These systems support effective treatment.
  • Focus On Combination Therapy Approaches: Combining different therapies is improving treatment outcomes. These approaches address complex disease mechanisms.

These developments are strengthening the capabilities of autoimmune treatments. Continuous innovation is enhancing effectiveness, accessibility, and patient care, supporting improved management of autoimmune diseases.

Strategic Growth Opportunities in the Autoimmune Treatment Market

The autoimmune treatment market presents strong growth opportunities driven by increasing disease prevalence and demand for advanced therapies. Expansion across key applications is creating new avenues for innovation and market development. Stakeholders are focusing on specialized areas to capture emerging demand.

  • Rheumatoid Arthritis Treatment Expansion Opportunity: Growing demand for effective therapies is driving development of advanced treatments. These solutions support improved disease management.
  • Psoriasis And Dermatology Treatment Growth Opportunity: Increasing focus on skin-related autoimmune conditions is creating opportunities for targeted therapies. These treatments enhance patient outcomes.
  • Inflammatory Bowel Disease Treatment Opportunity: Rising cases are driving demand for advanced therapies. These solutions support effective disease control.
  • Neurological Autoimmune Disorder Treatment Opportunity: Demand for treatments addressing neurological conditions is creating new opportunities. These therapies support improved patient care.
  • Rare Autoimmune Disease Treatment Development Opportunity: Focus on rare diseases is driving innovation in specialized therapies. These treatments address unmet needs.

Strategic growth opportunities are expanding across multiple therapeutic areas. Focus on advanced treatments and patient-centric approaches is supporting continued market development and innovation.

Autoimmune Treatment Market Driver and Challenges

The autoimmune treatment market is influenced by technological advancements, economic factors, and regulatory frameworks. These elements drive innovation while also presenting challenges that impact adoption and accessibility across healthcare systems.

The factors responsible for driving the autoimmune treatment market include:

  • Increasing Prevalence Of Autoimmune Diseases: Rising incidence of autoimmune conditions is driving demand for effective treatments. These therapies address growing healthcare needs.
  • Advancements In Biologic And Targeted Therapies: Continuous innovation is improving treatment effectiveness. These advancements support better disease management.
  • Growth In Healthcare Infrastructure Development: Expansion of healthcare systems is improving access to treatments. This supports market growth.
  • Rising Investment In Medical Research Activities: Increased research funding is driving development of new therapies. These efforts support innovation.
  • Demand For Personalized Treatment Approaches: Growing focus on individualized care is driving adoption of advanced therapies. These approaches improve outcomes.

The challenges facing the autoimmune treatment market include:

  • High Cost Of Advanced Therapies: Biologics and targeted treatments require significant investment, limiting accessibility.
  • Complex Regulatory Approval Processes: Strict regulations impact development and commercialization of new therapies.
  • Limited Awareness In Developing Regions: Lack of awareness and diagnosis challenges affect treatment adoption.

The autoimmune treatment market is shaped by strong demand for advanced therapies alongside notable challenges. While innovation and increasing prevalence drive growth, addressing cost, regulatory complexity, and awareness gaps remains essential for improving accessibility and ensuring sustainable market development.

List of Autoimmune Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autoimmune treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autoimmune treatment companies profiled in this report include-

  • AbbVie Inc
  • Amgen Inc
  • Johnson & Johnson
  • Eli Lilly & Co.
  • Pfizer Inc
  • F. Hoffmann-La Roche
  • AstraZeneca plc
  • Bristol-Myers Squibb
  • Lupin Ltd
  • GSK plc

Autoimmune Treatment Market by Segment

The study includes a forecast for the global autoimmune treatment market by type, indication, and region.

Autoimmune Treatment Market by Type [Value from 2019 to 2035]:

  • Drug Class
  • Surgery

Autoimmune Treatment Market by Indication [Value from 2019 to 2035]:

  • Rheumatic Disease
  • Type 1 Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Others

Autoimmune Treatment Market by Region [Value from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Autoimmune Treatment Market

The autoimmune treatment market is evolving rapidly as rising disease prevalence and advancements in immunology drive innovation. Biologics, targeted therapies, and personalized medicine approaches are transforming treatment strategies. Countries are focusing on improving diagnosis, expanding access to advanced therapies, and enhancing research capabilities to address complex autoimmune conditions across diverse patient populations.

  • United States: The market is driven by strong innovation in biologics and targeted therapies. Developments focus on monoclonal antibodies, immunomodulators, and personalized treatment approaches. Advanced research infrastructure and pharmaceutical investments are supporting new drug development and improved patient outcomes across multiple autoimmune disorders.
  • China: Rapid expansion of the healthcare sector is driving growth in autoimmune treatments. Developments emphasize domestic production of biologics and biosimilars, improving accessibility and affordability. Focus on expanding clinical research and regulatory support is strengthening the market.
  • Germany: Strong healthcare infrastructure is supporting development of advanced autoimmune therapies. Focus areas include biologics, precision medicine, and improved diagnostic capabilities. Collaboration within European healthcare systems is enhancing innovation and treatment accessibility.
  • India: Growing awareness and healthcare expansion are driving demand for autoimmune treatments. Developments include increased adoption of biosimilars and focus on cost-effective therapies. Government initiatives are supporting local production and improving access to advanced treatments.
  • Japan: Technological expertise is supporting development of innovative autoimmune therapies. Focus is on targeted treatments, biologics, and advanced diagnostic tools. Emphasis on research and precision medicine is enhancing treatment effectiveness.

Features of the Global Autoimmune Treatment Market

  • Market Size Estimates: Autoimmune treatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
  • Segmentation Analysis: Autoimmune treatment market size by type, indication, and region in terms of value ($B).
  • Regional Analysis: Autoimmune treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, indications, and regions for the autoimmune treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autoimmune treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the autoimmune treatment market by type (drug class and surgery), indication (rheumatic disease, type 1 diabetes, multiple sclerosis, inflammatory bowel disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Autoimmune Treatment Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Drug Class : Trends and Forecast (2019-2035)
  • 4.4 Surgery : Trends and Forecast (2019-2035)

5. Global Autoimmune Treatment Market by Indication

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Indication
  • 5.3 Rheumatic Disease : Trends and Forecast (2019-2035)
  • 5.4 Type 1 Diabetes : Trends and Forecast (2019-2035)
  • 5.5 Multiple Sclerosis : Trends and Forecast (2019-2035)
  • 5.6 Inflammatory Bowel Disease : Trends and Forecast (2019-2035)
  • 5.7 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Autoimmune Treatment Market by Region

7. North American Autoimmune Treatment Market

  • 7.1 Overview
  • 7.2 North American Autoimmune Treatment Market by Type
  • 7.3 North American Autoimmune Treatment Market by Indication
  • 7.4 The United States Autoimmune Treatment Market
  • 7.5 Canadian Autoimmune Treatment Market
  • 7.6 Mexican Autoimmune Treatment Market

8. European Autoimmune Treatment Market

  • 8.1 Overview
  • 8.2 European Autoimmune Treatment Market by Type
  • 8.3 European Autoimmune Treatment Market by Indication
  • 8.4 German Autoimmune Treatment Market
  • 8.5 French Autoimmune Treatment Market
  • 8.6 Italian Autoimmune Treatment Market
  • 8.7 Spanish Autoimmune Treatment Market
  • 8.8 The United Kingdom Autoimmune Treatment Market

9. APAC Autoimmune Treatment Market

  • 9.1 Overview
  • 9.2 APAC Autoimmune Treatment Market by Type
  • 9.3 APAC Autoimmune Treatment Market by Indication
  • 9.4 Chinese Autoimmune Treatment Market
  • 9.5 Indian Autoimmune Treatment Market
  • 9.6 Japanese Autoimmune Treatment Market
  • 9.7 South Korean Autoimmune Treatment Market
  • 9.8 Indonesian Autoimmune Treatment Market

10. ROW Autoimmune Treatment Market

  • 10.1 Overview
  • 10.2 ROW Autoimmune Treatment Market by Type
  • 10.3 ROW Autoimmune Treatment Market by Indication
  • 10.4 Middle Eastern Autoimmune Treatment Market
  • 10.5 South American Autoimmune Treatment Market
  • 10.6 African Autoimmune Treatment Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Indication
    • 12.2.3 Growth Opportunity by Region
  • 12.3 Emerging Trends in the Global Autoimmune Treatment Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 AbbVie Inc
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Amgen Inc
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Johnson & Johnson
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Eli Lilly & Co.
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Pfizer Inc
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 F. Hoffmann-La Roche
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 AstraZeneca plc
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Bristol-Myers Squibb
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Lupin Ltd
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 GSK plc
    • Company Overview
    • Autoimmune Treatment Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Autoimmune Treatment Market
  • Figure 2.1: Usage of Autoimmune Treatment Market
  • Figure 2.2: Classification of the Global Autoimmune Treatment Market
  • Figure 2.3: Supply Chain of the Global Autoimmune Treatment Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Autoimmune Treatment Market
  • Figure 4.1: Global Autoimmune Treatment Market by Type in 2019, 2025, and 2035
  • Figure 4.2: Trends of the Global Autoimmune Treatment Market ($B) by Type
  • Figure 4.3: Forecast for the Global Autoimmune Treatment Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Drug Class in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Surgery in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 5.1: Global Autoimmune Treatment Market by Indication in 2019, 2025, and 2035
  • Figure 5.2: Trends of the Global Autoimmune Treatment Market ($B) by Indication
  • Figure 5.3: Forecast for the Global Autoimmune Treatment Market ($B) by Indication
  • Figure 5.4: Trends and Forecast for Rheumatic Disease in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Type 1 Diabetes in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Multiple Sclerosis in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 5.7: Trends and Forecast for Inflammatory Bowel Disease in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 5.8: Trends and Forecast for Others in the Global Autoimmune Treatment Market (2019-2035)
  • Figure 6.1: Trends of the Global Autoimmune Treatment Market ($B) by Region (2019-2025)
  • Figure 6.2: Forecast for the Global Autoimmune Treatment Market ($B) by Region (2026-2035)
  • Figure 7.1: Trends and Forecast for the North American Autoimmune Treatment Market (2019-2035)
  • Figure 7.2: North American Autoimmune Treatment Market by Type in 2019, 2025, and 2035
  • Figure 7.3: Trends of the North American Autoimmune Treatment Market ($B) by Type (2019-2025)
  • Figure 7.4: Forecast for the North American Autoimmune Treatment Market ($B) by Type (2026-2035)
  • Figure 7.5: North American Autoimmune Treatment Market by Indication in 2019, 2025, and 2035
  • Figure 7.6: Trends of the North American Autoimmune Treatment Market ($B) by Indication (2019-2025)
  • Figure 7.7: Forecast for the North American Autoimmune Treatment Market ($B) by Indication (2026-2035)
  • Figure 7.8: Trends and Forecast for the United States Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Autoimmune Treatment Market (2019-2035)
  • Figure 8.2: European Autoimmune Treatment Market by Type in 2019, 2025, and 2035
  • Figure 8.3: Trends of the European Autoimmune Treatment Market ($B) by Type (2019-2025)
  • Figure 8.4: Forecast for the European Autoimmune Treatment Market ($B) by Type (2026-2035)
  • Figure 8.5: European Autoimmune Treatment Market by Indication in 2019, 2025, and 2035
  • Figure 8.6: Trends of the European Autoimmune Treatment Market ($B) by Indication (2019-2025)
  • Figure 8.7: Forecast for the European Autoimmune Treatment Market ($B) by Indication (2026-2035)
  • Figure 8.8: Trends and Forecast for the German Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Autoimmune Treatment Market (2019-2035)
  • Figure 9.2: APAC Autoimmune Treatment Market by Type in 2019, 2025, and 2035
  • Figure 9.3: Trends of the APAC Autoimmune Treatment Market ($B) by Type (2019-2025)
  • Figure 9.4: Forecast for the APAC Autoimmune Treatment Market ($B) by Type (2026-2035)
  • Figure 9.5: APAC Autoimmune Treatment Market by Indication in 2019, 2025, and 2035
  • Figure 9.6: Trends of the APAC Autoimmune Treatment Market ($B) by Indication (2019-2025)
  • Figure 9.7: Forecast for the APAC Autoimmune Treatment Market ($B) by Indication (2026-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Autoimmune Treatment Market (2019-2035)
  • Figure 10.2: ROW Autoimmune Treatment Market by Type in 2019, 2025, and 2035
  • Figure 10.3: Trends of the ROW Autoimmune Treatment Market ($B) by Type (2019-2025)
  • Figure 10.4: Forecast for the ROW Autoimmune Treatment Market ($B) by Type (2026-2035)
  • Figure 10.5: ROW Autoimmune Treatment Market by Indication in 2019, 2025, and 2035
  • Figure 10.6: Trends of the ROW Autoimmune Treatment Market ($B) by Indication (2019-2025)
  • Figure 10.7: Forecast for the ROW Autoimmune Treatment Market ($B) by Indication (2026-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Autoimmune Treatment Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Autoimmune Treatment Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Autoimmune Treatment Market (2025)
  • Figure 12.1: Growth Opportunities for the Global Autoimmune Treatment Market by Type
  • Figure 12.2: Growth Opportunities for the Global Autoimmune Treatment Market by Indication
  • Figure 12.3: Growth Opportunities for the Global Autoimmune Treatment Market by Region
  • Figure 12.4: Emerging Trends in the Global Autoimmune Treatment Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Autoimmune Treatment Market by Type and Indication
  • Table 1.2: Attractiveness Analysis for the Autoimmune Treatment Market by Region
  • Table 1.3: Global Autoimmune Treatment Market Parameters and Attributes
  • Table 3.1: Trends of the Global Autoimmune Treatment Market (2019-2025)
  • Table 3.2: Forecast for the Global Autoimmune Treatment Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global Autoimmune Treatment Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Autoimmune Treatment Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Autoimmune Treatment Market (2026-2035)
  • Table 4.4: Trends of Drug Class in the Global Autoimmune Treatment Market (2019-2025)
  • Table 4.5: Forecast for Drug Class in the Global Autoimmune Treatment Market (2026-2035)
  • Table 4.6: Trends of Surgery in the Global Autoimmune Treatment Market (2019-2025)
  • Table 4.7: Forecast for Surgery in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global Autoimmune Treatment Market by Indication
  • Table 5.2: Market Size and CAGR of Various Indication in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Indication in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.4: Trends of Rheumatic Disease in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.5: Forecast for Rheumatic Disease in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.6: Trends of Type 1 Diabetes in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.7: Forecast for Type 1 Diabetes in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.8: Trends of Multiple Sclerosis in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.9: Forecast for Multiple Sclerosis in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.10: Trends of Inflammatory Bowel Disease in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.11: Forecast for Inflammatory Bowel Disease in the Global Autoimmune Treatment Market (2026-2035)
  • Table 5.12: Trends of Others in the Global Autoimmune Treatment Market (2019-2025)
  • Table 5.13: Forecast for Others in the Global Autoimmune Treatment Market (2026-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Autoimmune Treatment Market (2019-2025)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Autoimmune Treatment Market (2026-2035)
  • Table 7.1: Trends of the North American Autoimmune Treatment Market (2019-2025)
  • Table 7.2: Forecast for the North American Autoimmune Treatment Market (2026-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Autoimmune Treatment Market (2019-2025)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Autoimmune Treatment Market (2026-2035)
  • Table 7.5: Market Size and CAGR of Various Indication in the North American Autoimmune Treatment Market (2019-2025)
  • Table 7.6: Market Size and CAGR of Various Indication in the North American Autoimmune Treatment Market (2026-2035)
  • Table 7.7: Trends and Forecast for the United States Autoimmune Treatment Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Autoimmune Treatment Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Autoimmune Treatment Market (2019-2035)
  • Table 8.1: Trends of the European Autoimmune Treatment Market (2019-2025)
  • Table 8.2: Forecast for the European Autoimmune Treatment Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Autoimmune Treatment Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the European Autoimmune Treatment Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Indication in the European Autoimmune Treatment Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Indication in the European Autoimmune Treatment Market (2026-2035)
  • Table 8.7: Trends and Forecast for the German Autoimmune Treatment Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Autoimmune Treatment Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Autoimmune Treatment Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Autoimmune Treatment Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Autoimmune Treatment Market (2019-2035)
  • Table 9.1: Trends of the APAC Autoimmune Treatment Market (2019-2025)
  • Table 9.2: Forecast for the APAC Autoimmune Treatment Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Autoimmune Treatment Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Autoimmune Treatment Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Indication in the APAC Autoimmune Treatment Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Indication in the APAC Autoimmune Treatment Market (2026-2035)
  • Table 9.7: Trends and Forecast for the Japanese Autoimmune Treatment Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Autoimmune Treatment Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Autoimmune Treatment Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Autoimmune Treatment Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Autoimmune Treatment Market (2019-2035)
  • Table 10.1: Trends of the ROW Autoimmune Treatment Market (2019-2025)
  • Table 10.2: Forecast for the ROW Autoimmune Treatment Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Autoimmune Treatment Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Autoimmune Treatment Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Indication in the ROW Autoimmune Treatment Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Indication in the ROW Autoimmune Treatment Market (2026-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Autoimmune Treatment Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Autoimmune Treatment Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Autoimmune Treatment Market (2019-2035)
  • Table 11.1: Product Mapping of Autoimmune Treatment Suppliers Based on Segments
  • Table 11.2: Operational Integration of Autoimmune Treatment Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Autoimmune Treatment Revenue
  • Table 12.1: New Product Launches by Major Autoimmune Treatment Producers (2019-2025)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Autoimmune Treatment Market